Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 7 Inhibition of SH2-domain containing tyrosine phosphatase-1 (SHP-1) enhances Rac1 activation mediated by phosphatidyl-inositol-3-kinase (PI3K). (Top) Pull-down assays of Rac1 human umbilical vein endothelial cell revealed increased amounts of active Rac1 (bound to GST-PAK) after sodium stibogluconate (SS) or antisense oligodesoxynucleotide (AS-ODN) against SHP-1; SS-induced Rac1-activation was inhibited by wortmannin (not shown). (Bottom) The ratio between blot densities of GTP-bound Rac1 to total Rac1 revealed significant induction of Rac1 activity by SHP-1 AS-ODN and by SS (means of three experiments).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement